Plant Health Care (LON:PHC)‘s stock had its “buy” rating reaffirmed by equities researchers at Liberum Capital in a report released on Tuesday. They presently have a GBX 45 ($0.61) target price on the stock. Liberum Capital’s target price would suggest a potential upside of 160.87% from the company’s previous close.

Shares of Plant Health Care (LON:PHC) opened at GBX 17.25 ($0.23) on Tuesday. Plant Health Care has a twelve month low of GBX 13 ($0.17) and a twelve month high of GBX 35 ($0.47).

ILLEGAL ACTIVITY WARNING: “Plant Health Care (PHC) Given “Buy” Rating at Liberum Capital” was reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another publication, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this report can be read at

Plant Health Care Company Profile

Plant Health Care plc provides agricultural biological products and technology solutions. The Company’s segments include Americas, Mexico, Rest of World and New Technology. The Company focuses on businesses, including New Technology and Commercial. Its Commercial business is focused on the sale of biological products.

Receive News & Ratings for Plant Health Care plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plant Health Care plc and related companies with's FREE daily email newsletter.